A randomized, placebo-controlled trial of extended-release guanfacine in children with autism spectrum disorder and ADHD symptoms: an analysis of secondary outcome measures

[1]  T. Rugino.  Effect on Primary Sleep Disorders When Children With ADHD Are Administered Guanfacine Extended Release , 2018, Journal of attention disorders.

[2]  O. Rahman,et al.  Extended-Release Guanfacine Does Not Show a Large Effect on Tic Severity in Children with Chronic Tic Disorders. , 2017, Journal of child and adolescent psychopharmacology.

[3]  M. Miclea,et al.  Child Symptom Inventory-4--Romanian Version , 2017 .

[4]  B. Robertson,et al.  Extended Release Guanfacine in Pediatric Anxiety Disorders: A Pilot, Randomized, Placebo-Controlled Trial. , 2017, Journal of child and adolescent psychopharmacology.

[5]  C. Lord,et al.  Autism Diagnostic Observation Schedule , 2016 .

[6]  Tristram H. Smith,et al.  Factor structure and psychometric properties of the revised Home Situations Questionnaire for autism spectrum disorder: The Home Situations Questionnaire-Autism Spectrum Disorder , 2016, Autism : the international journal of research and practice.

[7]  C. McDougle,et al.  Weight Gain and Metabolic Consequences of Risperidone in Young Children With Autism Spectrum Disorder. , 2016, Journal of the American Academy of Child and Adolescent Psychiatry.

[8]  Tristram H. Smith,et al.  Psychometric properties of the children's sleep habits questionnaire in children with autism spectrum disorder. , 2016, Sleep medicine.

[9]  Tristram H. Smith,et al.  Atomoxetine, Parent Training, and Their Combination in Children With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder. , 2015, Journal of the American Academy of Child and Adolescent Psychiatry.

[10]  C. McDougle,et al.  Extended-Release Guanfacine for Hyperactivity in Children With Autism Spectrum Disorder. , 2015, The American journal of psychiatry.

[11]  J. Martínez-Raga,et al.  Profile of guanfacine extended release and its potential in the treatment of attention-deficit hyperactivity disorder , 2015, Neuropsychiatric disease and treatment.

[12]  Lihai Song,et al.  Changing patterns of alpha agonist medication use in children and adolescents 2009-2011. , 2015, Journal of child and adolescent psychopharmacology.

[13]  Luc Lecavalier,et al.  Effect of parent training vs parent education on behavioral problems in children with autism spectrum disorder: a randomized clinical trial. , 2015, JAMA.

[14]  R. Findling,et al.  Guanfacine extended release adjunctive to a psychostimulant in the treatment of comorbid oppositional symptoms in children and adolescents with attention-deficit/hyperactivity disorder. , 2014, Journal of child and adolescent psychopharmacology.

[15]  D. Efron,et al.  Use of sleep medication in children with ADHD. , 2014, Sleep medicine.

[16]  C. McDougle,et al.  Psychopharmacological Interventions in Autism Spectrum Disorder , 2014, Harvard review of psychiatry.

[17]  D. Lane,et al.  Effects of extended release methylphenidate treatment on ratings of attention-deficit/hyperactivity disorder (ADHD) and associated behavior in children with autism spectrum disorders and ADHD symptoms. , 2013, Journal of child and adolescent psychopharmacology.

[18]  Janet B W Williams,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[19]  Alok Banga,et al.  An open-label study of guanfacine extended release for traumatic stress related symptoms in children and adolescents. , 2013, Journal of child and adolescent psychopharmacology.

[20]  F. Volkmar,et al.  Systematic Review and Meta-analysis of Pharmacological Treatment of the Symptoms of Attention-Deficit/Hyperactivity Disorder in Children with Pervasive Developmental Disorders , 2013, Journal of Autism and Developmental Disorders.

[21]  J. Bregman,et al.  Exploring the Manifestations of Anxiety in Children with Autism Spectrum Disorders , 2013, Journal of Autism and Developmental Disorders.

[22]  J. Buitelaar,et al.  A randomized double-blind study of atomoxetine versus placebo for attention-deficit/hyperactivity disorder symptoms in children with autism spectrum disorder. , 2012, Journal of the American Academy of Child and Adolescent Psychiatry.

[23]  Y. S. Kim,et al.  Global Prevalence of Autism and Other Pervasive Developmental Disorders , 2012, Autism research : official journal of the International Society for Autism Research.

[24]  F. Giannotti,et al.  Sleep in children with autism with and without autistic regression , 2011, Journal of sleep research.

[25]  C. McDougle,et al.  Medication and parent training in children with pervasive developmental disorders and serious behavior problems: results from a randomized clinical trial. , 2009, Journal of the American Academy of Child and Adolescent Psychiatry.

[26]  B. Malow,et al.  Parent-Based Sleep Education Workshops in Autism , 2009, Journal of child neurology.

[27]  E. Fombonne.  Epidemiology of Pervasive Developmental Disorders , 2009, Pediatric Research.

[28]  D. McCormick,et al.  α2A-Adrenoceptors Strengthen Working Memory Networks by Inhibiting cAMP-HCN Channel Signaling in Prefrontal Cortex , 2007, Cell.

[29]  C. McDougle,et al.  Positive Effects of Methylphenidate on Inattention and Hyperactivity in Pervasive Developmental Disorders: An Analysis of Secondary Measures , 2007, Biological Psychiatry.

[30]  W. Stone,et al.  Characterizing sleep in children with autism spectrum disorders: a multidimensional approach. , 2006, Sleep.

[31]  J. Buitelaar,et al.  Atomoxetine for attention-deficit/hyperactivity disorder symptoms in children with pervasive developmental disorders: a pilot study. , 2006, Journal of child and adolescent psychopharmacology.

[32]  Susan K. Williams,et al.  Children's Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders. , 2006, Journal of the American Academy of Child and Adolescent Psychiatry.

[33]  C. McDougle,et al.  Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. , 2005, Archives of general psychiatry.

[34]  C. McDougle,et al.  Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. , 2005, The American journal of psychiatry.

[35]  K. Gadow,et al.  Further Evidence of Reliability and Validity of the Child Symptom Inventory-4: Parent Checklist in Clinically Referred Boys , 2002, Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53.

[36]  J. Owens,et al.  The Children's Sleep Habits Questionnaire (CSHQ): psychometric properties of a survey instrument for school-aged children. , 2000, Sleep.

[37]  W. Goodman,et al.  Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[38]  M. Aman,et al.  The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects. , 1985, American journal of mental deficiency.

[39]  Catherine Lord,et al.  The Social Communication Questionnaire Manual , 2003 .

[40]  R. Barkley.  Assessing situational variation in children's problem behaviors : The home and school situations questionnaires , 1987 .